Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index; 11 of the 26 sources its claims cite were checked for support.

Autism spectrum disorder in ICD-11—a critical reflection of its possible impact on clinical practice and research

Open access
Kamp-Becker, Inge · 2024 · Molecular Psychiatry

Abstract

This perspective article compares and contrasts the conceptualization of Autism Spectrum Disorder (ASD) in ICD-11 and DSM-5. By guiding the user through the ICD-11 text, it is argued that, in contrast to DSM-5, ICD-11 allows a high variety in symptom combinations, which results in an operationalization of ASD that is in favor of an extreme diverse picture, yet possibly at the expense of precision, including unforeseeable effects on clinical practice, care, and research. The clinical utility is questionable as this conceptualization can hardly be differentiated from other mental disorders and autism-like traits. It moves away from an observable, behavioral, and neurodevelopmental disorder to a disorder of inner experience that can hardly be measured objectively. It contains many vague and subjective concepts that lead to non-falsifiable diagnoses. This bears a large danger of false positive diagnoses, of further increased prevalence rates, limitations of access to ASD-specific services and of increasing the non-specificity of treatments. For research, the hypothesis is that the specificity of ASD will be reduced and this will additional increase the already high heterogeneity with the effect that replication of studies will be hampered. This could limit our understanding of etiology and biological pathways of ASD and bears the risk that precision medicine, i.e., a targeted approach for individual treatment strategies based on precise diagnostic markers, is more far from becoming reality. Thus, a more precise, quantitative description and more objective measurement of symptoms are suggested that define the clinical ASD phenotype. Identification of core ASD subtypes/endophenotypes and a precise description of symptoms is the necessary next step to advance diagnostic classification systems. Therefore, employing a more finely grained, objective, clinical symptom characterization which is more relatable to neurobehavioral concepts is of central significance.

Overview

CoChat Summary

TL;DR

This perspective argues that ICD-11’s ASD conceptualization is broader and less prescriptive than DSM-5, allowing many symptom combinations and vague/subjective concepts, which may reduce specificity and increase false positives. It warns this could worsen heterogeneity, hamper replication and precision medicine, and limit access to ASD-specific services.

Key findings

  • ICD-11 lists 19 social communication/interaction manifestations and 16 restricted/repetitive features, yielding 304 possible combinations, with no mandatory social-communication criteria; the paper argues this broad operationalization risks arbitrary symptom presentations and false positive diagnoses.
  • The paper says ICD-11 moves away from an observable, behavioral, neurodevelopmental disorder toward a disorder of inner experience/identity, emphasizing compensation and symptoms “only apparent in retrospect”; compensation lacks an agreed definition and its empirical evidence is questionable, leading to non-falsifiable diagnoses.
  • Clinically, differentiation from other mental disorders and autism-like traits becomes difficult; around 80% of individuals with ASD have at least one comorbid disorder, and false positives may limit access for true positives and delay disorder-specific care.
  • For research, high heterogeneity already decreases effect sizes up to 80% in cognitive, EEG, and neuroanatomical studies and hampers replication; ICD-11 may further increase heterogeneity, limiting understanding of etiology/biological pathways and precision medicine.

Methods

  • Perspective/critical reflection article comparing ICD-11 and DSM-5 conceptualizations of ASD by guiding the reader through the ICD-11 text; all ICD-11 citations are from reference [11].
  • No empirical sample or primary data; the analysis is conceptual/textual, evaluating diagnostic requirements, specifiers, additional features, boundary with normality, differential diagnosis, and implications for clinical practice and research.
  • The author proposes more precise, quantitative, objective symptom characterization and identification of core ASD subtypes/endophenotypes.

Limitations

  • The paper states that the discussion about heterogeneity and prototypes is presented elsewhere and is “not the subject of this perspective article”; no formal limitations section is provided.
  • Evident from the text: it is a single-author perspective, not a systematic review or empirical test, so conclusions about ICD-11’s impact are hypotheses/projections rather than measured outcomes.
  • Evident from the text: it relies on textual analysis of ICD-11 and selected literature, with no new data to quantify false positives, prevalence changes, or service-access effects.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41380-023-02354-y

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

6 Valid · 0 Not valid · 9 Not checked · 23 Own results and interpretations

14 more claims

Create a free account to see all 38 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 9
  • Probably not a substantial claim. 14
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 71 references

Cited by

See all 63

Metadata

Authors
Kamp-Becker, I.
Venue
Molecular Psychiatry
Published
2024-01-25
Volume
29
Issue
3
Pages
633-638
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W4391225641
Cited by
63
References
71
Citations by year
2026: 22 · 2025: 28 · 2024: 13
FWCI
4.06
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PUBLISSO (German National Library of Medicine) (submittedVersion, other-oa)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
  • Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
Keywords
autism spectrum disorder, ICD-11, DSM-5, diagnostic classification, diagnostic criteria, symptom heterogeneity, false-positive diagnosis, autistic traits, autism prevalence, replication, precision medicine, endophenotypes, clinical practice
MeSH terms
Autism Spectrum Disorder, Child, Humans, International Classification of Diseases, Diagnostic and Statistical Manual of Mental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autism spectrum disorder in ICD-11—a critical reflection of its possible impact on clinical practice and research. https://app.cochat.ai/papers/10.1038/s41380-023-02354-y
The paper
Kamp-Becker, I. (2024). Autism spectrum disorder in ICD-11—a critical reflection of its possible impact on clinical practice and research. Molecular Psychiatry. https://doi.org/10.1038/s41380-023-02354-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.